Skip to content

Efficacy of the Third Eye Retroscope Auxiliary Imaging System

A Prospective Efficacy Evaluation of the Third Eye Retroscope Auxiliary Imaging System

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00657371
Enrollment
288
Registered
2008-04-14
Start date
2008-03-31
Completion date
2010-05-31
Last updated
2013-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer

Keywords

Colorectal Cancer, Colonoscopy, Third Eye Retroscope, Third Eye Retroscope Auxiliary Imaging System, Polypectomy

Brief summary

The purpose of this study is to demonstrate efficacy of the Avantis Third Eye Retroscope auxiliary imaging system. The primary objective of this study is to assess the degree to which incorporating the Third Eye Retroscope auxiliary imaging system in a screening colonoscopy setting results in the detection of additional polyps. Specifically, the primary goals are to estimate (1) the proportion of polyps detected under this protocol that would have been missed without the Third Eye Retroscope, and (2) the proportion of patients found under this protocol to have polyps who would have incorrectly been classified as polyp-free had the Third Eye Retroscope not been used.

Detailed description

THE STUDY DEVICE: The Third Eye Retroscope is a thin, flexible probe that can be inserted in a standard colonoscope in order to display very detailed images of the colon tissue. It contains a miniature video camera that allows the doctor to see an additional point of view that looks backward while the regular colonoscope and study device are moved together through the length of the colon. For you to be eligible to take part in this study, your doctor will check to be sure you have no medical conditions that would increase your risk of having any complications as a result of having the study device used during your colonoscopy. STUDY PROCEDURES: If you are found to be eligible to take part in this study, your doctor will perform your colonoscopy exam in the usual manner except that the Third Eye Retroscope device will be used during the exam as well. Your doctor will insert the colonoscope into your rectum in the usual manner and will then insert the study device down a channel inside the colonoscope. You will sign a separate consent form for the colonoscopy, which will describe the procedure and its risks in more detail. During the exam, you will be awake. If you have chosen to use medications for conscious sedation, you will be drowsy. FOLLOW-UP PHONE CALL: About 48 hours (2 days) after the study procedure, you will be called by the research staff to see how you are doing. After this follow-up call, your participation in this study will be over. This is an investigational study. The Third Eye Retroscope device is commercially available, but it is not FDA approved for this study's purpose. At this time, for this purpose, it is being used in research only. Up to 700 patients will take part in this study. Up to 100 will be enrolled at M. D. Anderson.

Interventions

DEVICEThird Eye Retroscope Auxiliary Imaging System

A thin, flexible probe that is inserted in a standard colonoscope in order to display very detailed images of the colon tissue.

Sponsors

Avantis Medical Systems
CollaboratorINDUSTRY
M.D. Anderson Cancer Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
50 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* The patient is undergoing colonoscopy for screening purposes or for surveillance in follow-up for previous polypectomy. * The patient is at satisfactory risk for abdominal surgery. * The patient must understand and provide written consent for the procedure.

Exclusion criteria

* Patients who are \<50 years or \>80 years of age * Patients who are pregnant. * Patients with history of colonic resection. * Patients requiring ongoing anticoagulation therapy. * Patients with a history of severe cardiovascular, pulmonary, liver or renal disease. * Patients with hypersensitivity to opioid analgesics. * Patients with an active systemic infection. * Patients with suspected chronic stricture potentially precluding complete colonoscopy. * Patients with major psychiatric disease (dementia, schizophrenia or depression). * Patients with diverticulitis or toxic megacolon. * Patients with history of radiation therapy to abdomen or pelvis. * Patients who are currently enrolled in another clinical investigation in which the intervention might compromise the safety of the patient's participation in this study.

Design outcomes

Primary

MeasureTime frameDescription
Increase (Percent) of Polyps Detected That Would Have Been Missed Without the Third Eye Retroscope (TER)Total 30 minutes procedure time with TER use.After cecal intubation, the disposable TER was inserted through the instrument channel of the colonoscope. During withdrawal, the forward and retrograde video images were observed simultaneously on a wide-screen monitor. A 2 year study period was used to collect colonoscopy exam results.
Number Polyps Detected With the Standard Colonoscope and Third Eye Retroscope (TER)Total 30 minutes procedure time with TER use.After cecal intubation, the disposable TER was inserted through the instrument channel of the colonoscope. During withdrawal, the forward and retrograde video images were observed simultaneously on a wide-screen monitor. A 2 year study period was used to collect colonoscopy exam results.

Secondary

MeasureTime frameDescription
Number Participants With Polyps Who Would Have Incorrectly Been Classified as Polyp-free Had the Third Eye Retroscope Not Been Used.2 year study period to collect colonoscopy exam resultsColonoscope and TER use where during TER withdrawal forward and retrograde video images observed simultaneously on a wide-screen monitor for purpose of detecting polyps. Colonoscopy procedures completed in approximately 30 minutes total.

Countries

United States

Participant flow

Recruitment details

Recruitment Period: March 05, 2008 to May 16, 2010 with recruitment completed in medical settings including university medical centers, ambulatory surgery centers, a community medical center and a physician's office.

Participants by arm

ArmCount
Third Eye Retroscope
Colonoscopy exam using the Third Eye Retroscope device
288
Total288

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyDevice- related reasons13
Overall StudyPoor bowel preparation15
Overall StudyPre-existing medical condition4
Overall StudyProtocol Violation2
Overall StudyUnable to intubate the cecum5

Baseline characteristics

CharacteristicThird Eye Retroscope
Age Continuous63 years
FULL_RANGE 6.5
Region of Enrollment
United States
288 participants
Sex: Female, Male
Female
156 Participants
Sex: Female, Male
Male
132 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 288
serious
Total, serious adverse events
0 / 288

Outcome results

Primary

Increase (Percent) of Polyps Detected That Would Have Been Missed Without the Third Eye Retroscope (TER)

After cecal intubation, the disposable TER was inserted through the instrument channel of the colonoscope. During withdrawal, the forward and retrograde video images were observed simultaneously on a wide-screen monitor. A 2 year study period was used to collect colonoscopy exam results.

Time frame: Total 30 minutes procedure time with TER use.

ArmMeasureValue (NUMBER)
Third Eye RetroscopeIncrease (Percent) of Polyps Detected That Would Have Been Missed Without the Third Eye Retroscope (TER)13.2 percent of polyps
Primary

Number Polyps Detected With the Standard Colonoscope and Third Eye Retroscope (TER)

After cecal intubation, the disposable TER was inserted through the instrument channel of the colonoscope. During withdrawal, the forward and retrograde video images were observed simultaneously on a wide-screen monitor. A 2 year study period was used to collect colonoscopy exam results.

Time frame: Total 30 minutes procedure time with TER use.

Population: Those polyps reported for Third Eye Retroscope were additional, located behind folds and then found with the colonscope only because they were first detected with the Third Eye Retroscope.

ArmMeasureGroupValue (NUMBER)
Third Eye RetroscopeNumber Polyps Detected With the Standard Colonoscope and Third Eye Retroscope (TER)Standard Colonoscope (Total)257 polyps
Third Eye RetroscopeNumber Polyps Detected With the Standard Colonoscope and Third Eye Retroscope (TER)Third Eye Retroscope34 polyps
Secondary

Number Participants With Polyps Who Would Have Incorrectly Been Classified as Polyp-free Had the Third Eye Retroscope Not Been Used.

Colonoscope and TER use where during TER withdrawal forward and retrograde video images observed simultaneously on a wide-screen monitor for purpose of detecting polyps. Colonoscopy procedures completed in approximately 30 minutes total.

Time frame: 2 year study period to collect colonoscopy exam results

Source: ClinicalTrials.gov · Data processed: Apr 1, 2026